ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

GNS Genus Plc

2,030.00
-20.00 (-0.98%)
14 Oct 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genus Plc LSE:GNS London Ordinary Share GB0002074580 ORD 10P
  Price Change % Change Share Price Shares Traded Last Trade
  -20.00 -0.98% 2,030.00 55,894 16:35:20
Bid Price Offer Price High Price Low Price Open Price
2,010.00 2,015.00 2,050.00 1,992.00 2,050.00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 668.8M 7.9M 0.1196 168.48 1.35B
Last Trade Time Trade Type Trade Size Trade Price Currency
16:35:20 AT 24 2,030.00 GBX

Genus (GNS) Latest News (1)

Genus (GNS) Discussions and Chat

Genus Forums and Chat

Date Time Title Posts
09/10/202416:03Genus with Charts222
25/5/200517:54BEEF UP THAT MACHO GENUS43
25/9/200200:06Genus - these todger tuggers are flying3
02/9/200219:43Is this stock very undervalued? - any more info22

Add a New Thread

Genus (GNS) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2024-10-14 15:35:202,030.0024487.20AT
2024-10-14 15:35:202,030.00781,583.40AT
2024-10-14 15:35:202,030.0050010,150.00AT
2024-10-14 15:35:202,030.0059812,139.40AT
2024-10-14 15:35:202,030.0024,347494,244.10UT

Genus (GNS) Top Chat Posts

Top Posts
Posted at 14/10/2024 09:20 by Genus Daily Update
Genus Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GNS. The last closing price for Genus was 2,050p.
Genus currently has 66,033,959 shares in issue. The market capitalisation of Genus is £1,330,584,274.
Genus has a price to earnings ratio (PE ratio) of 168.48.
This morning GNS shares opened at 2,050p
Posted at 09/10/2024 16:03 by indiestu
If the price holds into close then the gap from February is closed. That's very bullish for a long and steady rise as likely no sellers left in the game. It's been a little painful here for the past couple of years but maybe, just maybe it's turning. GLA holders.
Posted at 13/8/2024 09:30 by cerrito
I am not a holder here but watch.A good commentary on GNS by the Odyssean fund manager last week on Vox markets with Paul Hill.
Posted at 10/8/2024 12:22 by edwardt
The pork price rise has to be meaningful here
Posted at 03/11/2023 12:53 by edwardt
Think you are a bit optimistic there! I would say $100m with 90% margins five years out is about right for the US. This could easily be the same for China and throw in ROW and you might be near your figure. All in this could justify a tripling of the share price imho 2 to 3 years out once they start to ramp.
Posted at 11/10/2023 10:23 by the white house
Legging back in starting @ 22Decent update and long term v interesting prospects across the globeChina gov has been in the market stockpiling and boosted pork price by 25pc since JulyOne way bet from here
Posted at 18/7/2023 13:57 by edwardt
Not so fast. Let's see when they announce on their disease resistant pigs. The share price will fly...
Posted at 13/9/2022 21:46 by cerrito
I was interested to read Citywire's take of the recent Peel Hunt note
quote
Peel Hunt upgrades underappreciated Genus
Peel Hunt has upgraded Genus (GNS), which manufactures biotech and genetics products for cattle and pig farmers, after saying it is ‘back on the front foot’.

Analyst Charles Hall upgraded his recommendation from ‘hold’ to ‘buy’ but retained his target price of £45 on the stock, which shot up 16.7% to close at £27.98 on Thursday after a trading update.

Full-year 2022 was a challenging year for the group, with sharp declines in its China business as pork prices slumped, combining with pressure on producers from soaring input costs.

‘The outlook in China porcine now looks more encouraging, helped by the reduction in the sow herd and rising hog prices,’ said Hall.

‘Furthermore, commodity prices are adjusting to reflect the higher input costs.’

Despite ‘strong underlying performance, improved visibility in China, and currency benefit’, the shares have ‘materially derated and there is effectively nothing in the valuation for the significant potential in gene editing, which is on track for commercialisation in full-year 2024’.

Hall added ‘there is little doubt of the direction of travel for revenue prospects’ and there is ‘good cost management in place against the inflationary backdrop’.


unquote
Posted at 30/6/2021 11:34 by edwardt
Chinese govt stock piling pork - should help. Pork price rallying hard. Lots and lots to like in this stock - valuation is high but that is for good reason imo.
Posted at 09/3/2020 21:11 by thewheeliedealer
Hi all,

My mate Peter @Conkers3 and myself did another Podcast a few days ago and GNS was one of the Stocks that we rambled around. We also covered lots on the Markets and what we were expecting all this Virus stuff to mean. Anyway, if you use Apple or Audioboom you can find it under the 'Conkers Corner' Channel (you want TPI Podcast 18) and you can find it on Soundcloud on the link below.

Cheers, WD
@wheeliedealer
Posted at 30/10/2017 20:48 by chester
I was wondering why the price increased so much today.
Genus share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock